Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
28,079 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.
Weber M, Gimeno-Santos E, Wuyts M, Herrero-Cortina B, Troosters T, Puhan MA. · Cochrane Database Syst Rev · 2026 · cited 0 timesmeta-analysis, systematic review
- Metoprolol in Chronic Obstructive Pulmonary Disease without Cardiovascular Disease.
Sundh J, Magnuson A, Kvarnström M, Sjöberg F, Ekström M, Berglund JS, Ellingsen D, Wilhelms D, Hasselgren M, Cesarini SF, Blom KB, Blomberg A, Vanfleteren LEGW, Palm A, Smith C, Renström L, Ellingsen J, Janson C, Lundvall M, Delijaj F, Norberg E, Larsson B, Kipper T, Chowdhury Z, Jensen E, Stenberg H, Hårdstedt M, Ahmadi Z, Azizi K, Greger W, Montgomery S, Fröbert O. · NEJM Evid · 2026 · cited 0 timesmulticenter study, randomized controlled trial
- The Association Between Chronic Obstructive Pulmonary Disease and Postoperative Delirium: A Systematic Review and Meta-Analysis.
Wang Z, Xu J, Xi Y, Luo Z, Cheng J, Xu Z, Liang P. · Int J Chron Obstruct Pulmon Dis · 2026 · cited 0 timesmeta-analysis, systematic review
- Efficacy of opioid therapy in the management of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Chen L, Zhu K, Ge Y. · Medicine (Baltimore) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Microalbuminuria in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Erlac A, Diez-Manglano J. · Indian J Med Res · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Relationship between physical activity and muscle mass or quality in chronic obstructive pulmonary disease patients.
Sasaki S, Minakata Y, Ono H, Murakami Y, Takahashi K, Asai K, Nakanishi M, Hirano T, Matsunaga K. · Respir Investig · 2026 · cited 0 timesrandomized controlled trial
- Efficacy and Safety of Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease with Osteoporosis: A Systematic Review and Meta-Analysis.
Li X, Wang H, Zhang H, Hu X, Gao F, Wang B. · Int J Chron Obstruct Pulmon Dis · 2026 · cited 0 timesmeta-analysis, systematic review
- Toward a standardized framework for chronic obstructive pulmonary disease self-care: An umbrella review.
Zhou H, Yu DSF, Zhao Q, Zhang Y, Ip CH, Suen YN. · Int J Nurs Stud · 2026 · cited 0 timessystematic review
- Defining disease stability in chronic obstructive pulmonary disease: evidence from phase 3 clinical trials.
Singh D, Stacey R, Halpin DMG, Bhatt SP, Crawford J, Drury T, Di Boscio V, Kolterer S, Han MK. · Am J Respir Crit Care Med · 2026 · cited 3 timesOpen accessclinical trial, phase iii, randomized controlled trial
- Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.
Wedzicha JA, Agustí À, Brightling CE, Calverley P, Chalmers JD, Greening NJ, Han MK, Mohan D, Ng J, Papi A, Roche N, Saenz R, Samara K, Tal-Singer R, Vogelmeier CF, Yang X, Celli BR. · Am J Respir Crit Care Med · 2026 · cited 4 timesOpen accessrandomized controlled trial
- Chronic obstructive pulmonary disease and diabetes mellitus: a bidirectional meta-analysis of risk and comorbidity burden.
He S, Karunakaran M, Rushender R, Hariharan VS. · Front Endocrinol (Lausanne) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Evaluating the therapeutic benefit of bacterial lysates in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Almujadib A, Alotaibi R, Alsultan A, Alshehri R, Alzahrani HH, Almahfoodh N, Asiri B, Alsulami S, Alghool S, Saddiqi G, Hurst JR, Alotaibi HM, Althobiani MA. · Front Med (Lausanne) · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Circulating biomarkers linking heart failure and chronic obstructive pulmonary disease: Toward an integrated biological framework - A systematic review.
Corneanu LE, Petriş OR, Şorodoc V, Şorodoc L, Lionte C. · Biomed Pharmacother · 2026 · cited 0 timessystematic review
- Factors Associated With Regular Exercise Participation in Individuals With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
Choi JY, Cho S, Lim SY, Cho S. · J Gerontol Nurs · 2026 · cited 0 timesmeta-analysis, systematic review
- Clinical and transcriptomic characterization of mixed granulocytic phenotype in chronic obstructive pulmonary disease.
Leung C, Yoo JW, Park HY, Bhutta H, Sidhu P, Guinto E, Koelwyn GJ, Vahedi M, Li X, Eddy RL, Leipsic JA, Leitao Filho FS, Yang JS, Milne S, Takiguchi H, Akata K, Ra SW, Moon JY, Kim HK, Cho Y, Yamasaki K, van Eeden SF, Shaipanich T, Lam S, Leung JM, Sin DD. · J Allergy Clin Immunol · 2026 · cited 1 timesrandomized controlled trial
- Effectiveness of a Multicomponent Digital Therapeutic Program on Inhaled Medication Adherence in Chronic Obstructive Pulmonary Disease: Pilot Randomized Controlled Trial.
Wu H, Dong F, Cui Y, Hu D, Zhang Y, Peng T, Peng Y, Li X, Li Y, Li X, Chen Y, Yu Q, Niu H, Yang T. · JMIR Mhealth Uhealth · 2026 · cited 0 timesOpen accessrandomized controlled trial
- The effect of propolis oral care on oral mucositis in intensive care patients with chronic obstructive pulmonary disease: a randomized controlled trial.
Akyürek BNÖ, Korkut S, Küçük MÖ, Gürpınar AI. · Rev Assoc Med Bras (1992) · 2026 · cited 0 timesOpen accessrandomized controlled trial
- Effects of complementary therapies on physiological and psychological outcomes in chronic obstructive pulmonary disease patients: A systematic review and meta-analysis of randomized controlled trials.
Santiworakul A, Cetthakrikul S, Nemoto S, Nakabo T, Kuroyama Y, Khuna L, Longlalerng K. · Respir Med · 2026 · cited 0 timesmeta-analysis, systematic review
- The efficacy of N-acetylcysteine in the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Cai X, Peng S, Mao S, Zhong Y, Yu X. · PeerJ · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Association between history of pulmonary tuberculosis and chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Aken R, Li Y, Huang X, Abudusalamu N, Chen Y, Chen Z, Li Y. · Front Med (Lausanne) · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Health literacy-sensitive self-management interventions for chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Chen C, Zhan M, Zhang H. · NPJ Prim Care Respir Med · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Effectiveness of probiotic supplements in managing pulmonary function and inflammatory status in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Zhang Q, Zhang N, Zheng Y, Zhou J, Liu L, Dong G. · Clin Nutr · 2026 · cited 0 timesmeta-analysis, systematic review
- Biological therapy for chronic obstructive pulmonary disease (COPD): Effectiveness and safety.
García Morales OM, Díaz L, Auladell-Rispau A, Poloni D, Torres-López LA, Cuchi GU, Rojas-Reyes MX. · Respir Med · 2026 · cited 2 timesmeta-analysis, research support, non-u.s. gov't
- Dupilumab in chronic obstructive pulmonary disease: a pooled analysis of emergency department visits, hospital admissions, and systemic corticosteroid use.
Bhatt SP, Martinez FJ, Satia I, Anzueto A, Bourbeau J, Papi A, Korn S, Deslée G, Xia C, Heble J, Soliman M, Bafadhel M. · Am J Respir Crit Care Med · 2026 · cited 3 timesOpen accessclinical trial, phase iii, randomized controlled trial
- Global prevalence and risk factors of osteoporosis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Yu C, Teng X, Du W, Ma X, Yu C, Xia Y, Hui J, Xie F, Li J, Hu S. · BMC Public Health · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.